Home
Conditions
Lung Diseases, Interstitial

Clinical trial condition

Lung Diseases, Interstitial

Explore clinical trials studying Lung Diseases, Interstitial. Study availability and eligibility vary by location and protocol.

725 public trials 133 recruiting studies

Refine in advanced search Browse all conditions

Lung Diseases, Interstitial trial results

Not Yet Recruiting

A Seamless, Adaptive Multiple-Ascending-Dose and Efficacy Study of XTMAB-16 in Patients With Pulmonary Sarcoidosis With or Without Extrapulmonary Manifestations

NCT07680166

Conditions: Hemic and Lymphatic Diseases, Hypersensitivity, Hypersensitivity, Delayed, +9 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Study of Single and Multiple Oral Doses of SCB0020160 in Healthy Adult Male Subjects

NCT07682337

Conditions: Body Weight, Idiopathic Pulmonary Fibrosis, Lung Diseases, +11 more
Locations: CMAX Clinical Research Pty Ltd Ground Floor, 21-24 North Terrace Adelaide, South Australia, Australia

View Trial Details

Not Yet Recruiting

Autoantibody Reduction Therapy for Progressive Idiopathic Pulmonary Fibrosis

NCT07674745

Conditions: Disease Attributes, Disease Progression, Idiopathic Pulmonary Fibrosis, +6 more
Locations: University of Alabama at Birmingham Birmingham, Alabama, United States

Loyola University Chicago, Illinois, United States

Northwestern University Chicago, Illinois, United States

University of Kansas Kansas City, Kansas, United States

View Trial Details

Not Yet Recruiting

Evaluation of the Efficacy and Safety of Compound Betamethasone in Pulmonary Sarcoidosis

NCT07668895

Conditions: Hemic and Lymphatic Diseases, Hypersensitivity, Hypersensitivity, Delayed, +8 more
Locations: Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College Beijing, Beijing Municipality, China

View Trial Details

Not Yet Recruiting

TAVNEOS for Otolaryngologic Manifestations of Granulomatosis With Polyangiitis

NCT07176546

Conditions: Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Autoimmune Diseases, Cardiovascular Diseases, +14 more
Locations: Hackensack Meridian School of Medicine - Advanced Lung and Airway Center Edison, New Jersey, United States

Hospital for Special Surgery New York, United States

View Trial Details

Not Yet Recruiting

A Phase II Study to Evaluate the Efficacy and Safety of SYH2059 Tablets in Adult Patients With Idiopathic Pulmonary Fibrosis

NCT07600021

Conditions: Idiopathic Pulmonary Fibrosis, Lung Diseases, Lung Diseases, Interstitial, +2 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

A Phase I Study of HW241045 in Healthy Subjects

NCT07593690

Conditions: Idiopathic Pulmonary Fibrosis, Idiopathic Pulmonary Fibrosis (IPF), Lung Diseases, +3 more
Locations: The First Affiliated Hospital of Shandong First Medical University(Shandong Provincial Qianfoshan Hospital) Jinan, Shandong, China

View Trial Details

Not Yet Recruiting

Nintedanib With or Without Dextromethorphan in Patients With Idiopathic Pulmonary Fibrosis (IPF)

NCT07583589

Conditions: Idiopathic Pulmonary Fibrosis, Idiopathic Pulmonary Fibrosis (IPF), Lung Diseases, +3 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Metformin to Attenuate Progressive Respiratory Decline in Idiopathic Pulmonary Fibrosis

NCT07520110

Conditions: Idiopathic Pulmonary Fibrosis, Lung Diseases, Lung Diseases, Interstitial, +2 more
Locations: University of Massachusetts Chan Medical School Worcester, Massachusetts, United States

View Trial Details

Not Yet Recruiting

Safety and Efficacy of Nebulized 3D-cultured Human Placental Mesenchymal Stem Cell-derived Extracellular Vesicles (hPMSC-EVs) for Idiopathic Pulmonary Fibrosis

NCT07515066

Conditions: Idiopathic Pulmonary Fibrosis, Idiopathic Pulmonary Fibrosis (IPF), Lung Diseases, +3 more
Locations: Beijing Chest Hospital, Capital Medical University Beijing, China

View Trial Details

Lung Diseases, Interstitial

Lung Diseases, Interstitial trial results

Related conditions